MedPath

Diclofenac Potassium

Diclofenac Potassium Tablets, USP 25 mg

Approved
Approval ID

bce95bb3-3097-4e7d-8d29-0870bb729212

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 8, 2023

Manufacturers
FDA

CARWIN PHARMACEUTICAL ASSOCIATES, LLC

DUNS: 079217215

FDA

Carwin Pharmaceutical Associates, LLC

DUNS: 079217215

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DICLOFENAC POTASSIUM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code15370-185
Application NumberANDA076561
Product Classification
M
Marketing Category
C73584
G
Generic Name
DICLOFENAC POTASSIUM
Product Specifications
Route of AdministrationORAL
Effective DateNovember 8, 2023
FDA Product Classification

INGREDIENTS (1)

DICLOFENAC POTASSIUMActive
Quantity: 25 mg in 1 1
Code: L4D5UA6CB4
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diclofenac Potassium - FDA Drug Approval Details